Anxiety Disorders Drugs Market Report

Europe Anxiety Disorders Drugs Market Size, Status and Forecast 2014-2026

  • POSTDATE：Oct 12, 2019
  • PAGES：147
  • REPORT CODE：GMM315919
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Anxiety Disorders Drugs market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 14.6% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Anxiety Disorders Drugs Market Segmentations:

    By Player:

    • C4X Discovery Holdings PLC

    • Azevan Pharmaceuticals, Inc.

    • Bionomics Limited.

    • Eisai Co, Ltd.

    • HolsboerMaschmeyer NeuroChemie GmbH.

    • Intra-Cellular Therapies, Inc

    • Adamed Sp z oo.

    • Catalyst Pharmaceutical Partners, Inc

    • Marinus Pharmaceuticals, Inc.

    • AbbVie Inc.

    • IntelGenx Corp

    • INVENT Pharmaceuticals, Inc

    • Amorsa Therapeutics Inc.

    • F. Hoffmann-La Roche Ltd.

    • F Hoffmann-La Roche Ltd

    • Avineuro Pharmaceuticals, Inc

    • Addex Therapeutics Ltd

    • GW Pharmaceuticals Plc

    • Boehringer Ingelheim GmbH.

    • Adamed Sp. z o.o.

    • Eisai Co., Ltd.

    • Edgemont Pharmaceuticals, LLC

    • Eli Lilly and Company

    By Type:

    • Type 1

    • Type 2

    • Type 3

    By End-User:

    • End-Users 1

    • End-Users 2

    • End-Users 3

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Anxiety Disorders Drugs Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Anxiety Disorders Drugs Market Size and Growth Rate of Type 1 from 2014 to 2026

    • 1.3.2 Europe Anxiety Disorders Drugs Market Size and Growth Rate of Type 2 from 2014 to 2026

    • 1.3.3 Europe Anxiety Disorders Drugs Market Size and Growth Rate of Type 3 from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Anxiety Disorders Drugs Market Size and Growth Rate of End-User 1 from 2014 to 2026

    • 1.4.2 Europe Anxiety Disorders Drugs Market Size and Growth Rate of End-User 2 from 2014 to 2026

    • 1.4.3 Europe Anxiety Disorders Drugs Market Size and Growth Rate of End-User 3 from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Anxiety Disorders Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Anxiety Disorders Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Anxiety Disorders Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Anxiety Disorders Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Anxiety Disorders Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Anxiety Disorders Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Anxiety Disorders Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Anxiety Disorders Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Anxiety Disorders Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Anxiety Disorders Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Anxiety Disorders Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Anxiety Disorders Drugs Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Anxiety Disorders Drugs Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Anxiety Disorders Drugs by Major Types

      • 3.4.1 Market Size and Growth Rate of Type 1

      • 3.4.2 Market Size and Growth Rate of Type 2

      • 3.4.3 Market Size and Growth Rate of Type 3

    4 Segmentation of Anxiety Disorders Drugs Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Anxiety Disorders Drugs by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Anxiety Disorders Drugs for End-Users 1

      • 4.4.2 Market Size and Growth Rate of Anxiety Disorders Drugs for End-Users 2

      • 4.4.3 Market Size and Growth Rate of Anxiety Disorders Drugs for End-Users 3

    5 Market Analysis by Major Regions

    • 5.1 Europe Anxiety Disorders Drugs Production Analysis by Top Regions

    • 5.2 Europe Anxiety Disorders Drugs Consumption Analysis by Top Regions

    • 5.3 Europe Anxiety Disorders Drugs Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Anxiety Disorders Drugs Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Anxiety Disorders Drugs Production, Import, Consumption and Export Analysis

      • 5.3.3 France Anxiety Disorders Drugs Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Anxiety Disorders Drugs Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Anxiety Disorders Drugs Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Anxiety Disorders Drugs Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Anxiety Disorders Drugs Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Anxiety Disorders Drugs Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Anxiety Disorders Drugs Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Anxiety Disorders Drugs Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Anxiety Disorders Drugs Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Anxiety Disorders Drugs Production, Import, Consumption and Export Analysis

    6 Product Circulation of Anxiety Disorders Drugs Market among Top Countries

    • 6.1 Top 5 Export Countries in Anxiety Disorders Drugs Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Anxiety Disorders Drugs Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Anxiety Disorders Drugs Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Anxiety Disorders Drugs Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Anxiety Disorders Drugs Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Anxiety Disorders Drugs Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Anxiety Disorders Drugs Landscape Analysis

    • 7.1 Germany Anxiety Disorders Drugs Landscape Analysis by Major Types

    • 7.2 Germany Anxiety Disorders Drugs Landscape Analysis by Major End-Users

    8. UK Anxiety Disorders Drugs Landscape Analysis

    • 8.1 UK Anxiety Disorders Drugs Landscape Analysis by Major Types

    • 8.2 UK Anxiety Disorders Drugs Landscape Analysis by Major End-Users

    9. France Anxiety Disorders Drugs Landscape Analysis

    • 9.1 France Anxiety Disorders Drugs Landscape Analysis by Major Types

    • 9.2 France Anxiety Disorders Drugs Landscape Analysis by Major End-Users

    10. Italy Anxiety Disorders Drugs Landscape Analysis

    • 10.1 Italy Anxiety Disorders Drugs Landscape Analysis by Major Types

    • 10.2 Italy Anxiety Disorders Drugs Landscape Analysis by Major End-Users

    11. Spain Anxiety Disorders Drugs Landscape Analysis

    • 11.1 Spain Anxiety Disorders Drugs Landscape Analysis by Major Types

    • 11.2 Spain Anxiety Disorders Drugs Landscape Analysis by Major End-Users

    12. Poland Anxiety Disorders Drugs Landscape Analysis

    • 12.1 Poland Anxiety Disorders Drugs Landscape Analysis by Major Types

    • 12.2 Poland Anxiety Disorders Drugs Landscape Analysis by Major End-Users

    13. Russia Anxiety Disorders Drugs Landscape Analysis

    • 13.1 Russia Anxiety Disorders Drugs Landscape Analysis by Major Types

    • 13.2 Russia Anxiety Disorders Drugs Landscape Analysis by Major End-Users

    14. Switzerland Anxiety Disorders Drugs Landscape Analysis

    • 14.1 Switzerland Anxiety Disorders Drugs Landscape Analysis by Major Types

    • 14.2 Switzerland Anxiety Disorders Drugs Landscape Analysis by Major End-Users

    15. Turkey Anxiety Disorders Drugs Landscape Analysis

    • 15.1 Turkey Anxiety Disorders Drugs Landscape Analysis by Major Types

    • 15.2 Turkey Anxiety Disorders Drugs Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Anxiety Disorders Drugs Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Anxiety Disorders Drugs Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Anxiety Disorders Drugs Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Anxiety Disorders Drugs Landscape Analysis by Top Countries

      • 16.3.1 Denmark Anxiety Disorders Drugs Market Volume and Growth Rate

      • 16.3.2 Finland Anxiety Disorders Drugs Market Volume and Growth Rate

      • 16.3.3 Norway Anxiety Disorders Drugs Market Volume and Growth Rate

      • 16.3.4 Sweden Anxiety Disorders Drugs Market Volume and Growth Rate

      • 16.3.6 Iceland Anxiety Disorders Drugs Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Anxiety Disorders Drugs Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Anxiety Disorders Drugs Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Anxiety Disorders Drugs Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Anxiety Disorders Drugs Landscape Analysis by Top Countries

      • 17.3.1 Belgium Anxiety Disorders Drugs Market Volume and Growth Rate

      • 17.3.2 Netherlands Anxiety Disorders Drugs Market Volume and Growth Rate

      • 17.3.3 Luxembourg Anxiety Disorders Drugs Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Anxiety Disorders Drugs Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Anxiety Disorders Drugs Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Anxiety Disorders Drugs Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Anxiety Disorders Drugs Landscape Analysis by Top Countries

      • 18.3.1 Estonia Anxiety Disorders Drugs Market Volume and Growth Rate

      • 18.3.2 Latvia Anxiety Disorders Drugs Market Volume and Growth Rate

      • 18.3.3 Lithuania Anxiety Disorders Drugs Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 C4X Discovery Holdings PLC

      • 19.1.1 C4X Discovery Holdings PLC Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Azevan Pharmaceuticals, Inc.

      • 19.2.1 Azevan Pharmaceuticals, Inc. Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Bionomics Limited.

      • 19.3.1 Bionomics Limited. Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Eisai Co, Ltd.

      • 19.4.1 Eisai Co, Ltd. Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 HolsboerMaschmeyer NeuroChemie GmbH.

      • 19.5.1 HolsboerMaschmeyer NeuroChemie GmbH. Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Intra-Cellular Therapies, Inc

      • 19.6.1 Intra-Cellular Therapies, Inc Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Adamed Sp z oo.

      • 19.7.1 Adamed Sp z oo. Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Catalyst Pharmaceutical Partners, Inc

      • 19.8.1 Catalyst Pharmaceutical Partners, Inc Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Marinus Pharmaceuticals, Inc.

      • 19.9.1 Marinus Pharmaceuticals, Inc. Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 AbbVie Inc.

      • 19.10.1 AbbVie Inc. Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 IntelGenx Corp

      • 19.11.1 IntelGenx Corp Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 INVENT Pharmaceuticals, Inc

      • 19.12.1 INVENT Pharmaceuticals, Inc Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Amorsa Therapeutics Inc.

      • 19.13.1 Amorsa Therapeutics Inc. Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 F. Hoffmann-La Roche Ltd.

      • 19.14.1 F. Hoffmann-La Roche Ltd. Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 F Hoffmann-La Roche Ltd

      • 19.15.1 F Hoffmann-La Roche Ltd Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    • 19.16 Avineuro Pharmaceuticals, Inc

      • 19.16.1 Avineuro Pharmaceuticals, Inc Company Profile and Development Status

      • 19.16.2 Market Performance

      • 19.16.3 Product and Service Introduction

    • 19.17 Addex Therapeutics Ltd

      • 19.17.1 Addex Therapeutics Ltd Company Profile and Development Status

      • 19.17.2 Market Performance

      • 19.17.3 Product and Service Introduction

    • 19.18 GW Pharmaceuticals Plc

      • 19.18.1 GW Pharmaceuticals Plc Company Profile and Development Status

      • 19.18.2 Market Performance

      • 19.18.3 Product and Service Introduction

    • 19.19 Boehringer Ingelheim GmbH.

      • 19.19.1 Boehringer Ingelheim GmbH. Company Profile and Development Status

      • 19.19.2 Market Performance

      • 19.19.3 Product and Service Introduction

    • 19.20 Adamed Sp. z o.o.

      • 19.20.1 Adamed Sp. z o.o. Company Profile and Development Status

      • 19.20.2 Market Performance

      • 19.20.3 Product and Service Introduction

    • 19.21 Eisai Co., Ltd.

      • 19.21.1 Eisai Co., Ltd. Company Profile and Development Status

      • 19.21.2 Market Performance

      • 19.21.3 Product and Service Introduction

    • 19.22 Edgemont Pharmaceuticals, LLC

      • 19.22.1 Edgemont Pharmaceuticals, LLC Company Profile and Development Status

      • 19.22.2 Market Performance

      • 19.22.3 Product and Service Introduction

    • 19.23 Eli Lilly and Company

      • 19.23.1 Eli Lilly and Company Company Profile and Development Status

      • 19.23.2 Market Performance

      • 19.23.3 Product and Service Introduction

    The List of Tables and Figures (Totals 100 Figures and 130 Tables)

    • Figure Product Picture

    • Figure Europe Anxiety Disorders Drugs Market Size and Growth Rate of Type 1 from 2014 to 2026

    • Figure Europe Anxiety Disorders Drugs Market Size and Growth Rate of Type 2 from 2014 to 2026

    • Figure Europe Anxiety Disorders Drugs Market Size and Growth Rate of Type 3 from 2014 to 2026

    • Figure Europe Anxiety Disorders Drugs Market Size and Growth Rate of End-User 1 from 2014 to 2026

    • Figure Europe Anxiety Disorders Drugs Market Size and Growth Rate of End-User 2 from 2014 to 2026

    • Figure Europe Anxiety Disorders Drugs Market Size and Growth Rate of End-User 3 from 2014 to 2026

    • Figure Germany Anxiety Disorders Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure UK Anxiety Disorders Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure France Anxiety Disorders Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Anxiety Disorders Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Anxiety Disorders Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Anxiety Disorders Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Anxiety Disorders Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Anxiety Disorders Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Anxiety Disorders Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Anxiety Disorders Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Anxiety Disorders Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Anxiety Disorders Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Anxiety Disorders Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Anxiety Disorders Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Anxiety Disorders Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Anxiety Disorders Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Anxiety Disorders Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Anxiety Disorders Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Anxiety Disorders Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Anxiety Disorders Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Anxiety Disorders Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Anxiety Disorders Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Anxiety Disorders Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Anxiety Disorders Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Anxiety Disorders Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Anxiety Disorders Drugs Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Anxiety Disorders Drugs

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Anxiety Disorders Drugs by Different Types from 2014 to 2026

    • Table Consumption Share of Anxiety Disorders Drugs by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Type 1

    • Figure Market Size and Growth Rate of Type 2

    • Figure Market Size and Growth Rate of Type 3

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Anxiety Disorders Drugs by Different End-Users from 2014 to 2026

    • Table Consumption Share of Anxiety Disorders Drugs by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of End-User 1

    • Figure Market Size and Growth Rate of End-User 2

    • Figure Market Size and Growth Rate of End-User 3

    • Table Europe Anxiety Disorders Drugs Production by Major Regions

    • Table Europe Anxiety Disorders Drugs Production Share by Major Regions

    • Figure Europe Anxiety Disorders Drugs Production Share by Major Countries and Regions in 2014

    • Table Europe Anxiety Disorders Drugs Consumption by Major Regions

    • Table Europe Anxiety Disorders Drugs Consumption Share by Major Regions

    • Table Germany Anxiety Disorders Drugs Production, Import, Consumption and Export Analysis

    • Table UK Anxiety Disorders Drugs Production, Import, Consumption and Export Analysis

    • Table France Anxiety Disorders Drugs Production, Import, Consumption and Export Analysis

    • Table Italy Anxiety Disorders Drugs Production, Import, Consumption and Export Analysis

    • Table Spain Anxiety Disorders Drugs Production, Import, Consumption and Export Analysis

    • Table Poland Anxiety Disorders Drugs Production, Import, Consumption and Export Analysis

    • Table Russia Anxiety Disorders Drugs Production, Import, Consumption and Export Analysis

    • Table Switzerland Anxiety Disorders Drugs Production, Import, Consumption and Export Analysis

    • Table Turkey Anxiety Disorders Drugs Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Anxiety Disorders Drugs Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Anxiety Disorders Drugs Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Anxiety Disorders Drugs Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Anxiety Disorders Drugs Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Anxiety Disorders Drugs Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Anxiety Disorders Drugs Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Anxiety Disorders Drugs Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Anxiety Disorders Drugs Consumption by Types from 2014 to 2026

    • Table Germany Anxiety Disorders Drugs Consumption Share by Types from 2014 to 2026

    • Table Germany Anxiety Disorders Drugs Consumption by End-Users from 2014 to 2026

    • Table Germany Anxiety Disorders Drugs Consumption Share by End-Users from 2014 to 2026

    • Table UK Anxiety Disorders Drugs Consumption by Types from 2014 to 2026

    • Table UK Anxiety Disorders Drugs Consumption Share by Types from 2014 to 2026

    • Table UK Anxiety Disorders Drugs Consumption by End-Users from 2014 to 2026

    • Table UK Anxiety Disorders Drugs Consumption Share by End-Users from 2014 to 2026

    • Table France Anxiety Disorders Drugs Consumption by Types from 2014 to 2026

    • Table France Anxiety Disorders Drugs Consumption Share by Types from 2014 to 2026

    • Table France Anxiety Disorders Drugs Consumption by End-Users from 2014 to 2026

    • Table France Anxiety Disorders Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Italy Anxiety Disorders Drugs Consumption by Types from 2014 to 2026

    • Table Italy Anxiety Disorders Drugs Consumption Share by Types from 2014 to 2026

    • Table Italy Anxiety Disorders Drugs Consumption by End-Users from 2014 to 2026

    • Table Italy Anxiety Disorders Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Spain Anxiety Disorders Drugs Consumption by Types from 2014 to 2026

    • Table Spain Anxiety Disorders Drugs Consumption Share by Types from 2014 to 2026

    • Table Spain Anxiety Disorders Drugs Consumption by End-Users from 2014 to 2026

    • Table Spain Anxiety Disorders Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Poland Anxiety Disorders Drugs Consumption by Types from 2014 to 2026

    • Table Poland Anxiety Disorders Drugs Consumption Share by Types from 2014 to 2026

    • Table Poland Anxiety Disorders Drugs Consumption by End-Users from 2014 to 2026

    • Table Poland Anxiety Disorders Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Russia Anxiety Disorders Drugs Consumption by Types from 2014 to 2026

    • Table Russia Anxiety Disorders Drugs Consumption Share by Types from 2014 to 2026

    • Table Russia Anxiety Disorders Drugs Consumption by End-Users from 2014 to 2026

    • Table Russia Anxiety Disorders Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Anxiety Disorders Drugs Consumption by Types from 2014 to 2026

    • Table Switzerland Anxiety Disorders Drugs Consumption Share by Types from 2014 to 2026

    • Table Switzerland Anxiety Disorders Drugs Consumption by End-Users from 2014 to 2026

    • Table Switzerland Anxiety Disorders Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Anxiety Disorders Drugs Consumption by Types from 2014 to 2026

    • Table Turkey Anxiety Disorders Drugs Consumption Share by Types from 2014 to 2026

    • Table Turkey Anxiety Disorders Drugs Consumption by End-Users from 2014 to 2026

    • Table Turkey Anxiety Disorders Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Anxiety Disorders Drugs Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Anxiety Disorders Drugs Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Anxiety Disorders Drugs Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Anxiety Disorders Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Anxiety Disorders Drugs Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Anxiety Disorders Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Anxiety Disorders Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Anxiety Disorders Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Anxiety Disorders Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Anxiety Disorders Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Anxiety Disorders Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Anxiety Disorders Drugs Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Anxiety Disorders Drugs Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Anxiety Disorders Drugs Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Anxiety Disorders Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Anxiety Disorders Drugs Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Anxiety Disorders Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Anxiety Disorders Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Anxiety Disorders Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Anxiety Disorders Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Anxiety Disorders Drugs Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Anxiety Disorders Drugs Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Anxiety Disorders Drugs Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Anxiety Disorders Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Anxiety Disorders Drugs Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Anxiety Disorders Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Anxiety Disorders Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Anxiety Disorders Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Anxiety Disorders Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of C4X Discovery Holdings PLC

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of C4X Discovery Holdings PLC

    • Figure Sales and Growth Rate Analysis of C4X Discovery Holdings PLC

    • Figure Revenue and Market Share Analysis of C4X Discovery Holdings PLC

    • Table Product and Service Introduction of C4X Discovery Holdings PLC

    • Table Company Profile and Development Status of Azevan Pharmaceuticals, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Azevan Pharmaceuticals, Inc.

    • Figure Sales and Growth Rate Analysis of Azevan Pharmaceuticals, Inc.

    • Figure Revenue and Market Share Analysis of Azevan Pharmaceuticals, Inc.

    • Table Product and Service Introduction of Azevan Pharmaceuticals, Inc.

    • Table Company Profile and Development Status of Bionomics Limited.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bionomics Limited.

    • Figure Sales and Growth Rate Analysis of Bionomics Limited.

    • Figure Revenue and Market Share Analysis of Bionomics Limited.

    • Table Product and Service Introduction of Bionomics Limited.

    • Table Company Profile and Development Status of Eisai Co, Ltd.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eisai Co, Ltd.

    • Figure Sales and Growth Rate Analysis of Eisai Co, Ltd.

    • Figure Revenue and Market Share Analysis of Eisai Co, Ltd.

    • Table Product and Service Introduction of Eisai Co, Ltd.

    • Table Company Profile and Development Status of HolsboerMaschmeyer NeuroChemie GmbH.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of HolsboerMaschmeyer NeuroChemie GmbH.

    • Figure Sales and Growth Rate Analysis of HolsboerMaschmeyer NeuroChemie GmbH.

    • Figure Revenue and Market Share Analysis of HolsboerMaschmeyer NeuroChemie GmbH.

    • Table Product and Service Introduction of HolsboerMaschmeyer NeuroChemie GmbH.

    • Table Company Profile and Development Status of Intra-Cellular Therapies, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Intra-Cellular Therapies, Inc

    • Figure Sales and Growth Rate Analysis of Intra-Cellular Therapies, Inc

    • Figure Revenue and Market Share Analysis of Intra-Cellular Therapies, Inc

    • Table Product and Service Introduction of Intra-Cellular Therapies, Inc

    • Table Company Profile and Development Status of Adamed Sp z oo.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Adamed Sp z oo.

    • Figure Sales and Growth Rate Analysis of Adamed Sp z oo.

    • Figure Revenue and Market Share Analysis of Adamed Sp z oo.

    • Table Product and Service Introduction of Adamed Sp z oo.

    • Table Company Profile and Development Status of Catalyst Pharmaceutical Partners, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Catalyst Pharmaceutical Partners, Inc

    • Figure Sales and Growth Rate Analysis of Catalyst Pharmaceutical Partners, Inc

    • Figure Revenue and Market Share Analysis of Catalyst Pharmaceutical Partners, Inc

    • Table Product and Service Introduction of Catalyst Pharmaceutical Partners, Inc

    • Table Company Profile and Development Status of Marinus Pharmaceuticals, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Marinus Pharmaceuticals, Inc.

    • Figure Sales and Growth Rate Analysis of Marinus Pharmaceuticals, Inc.

    • Figure Revenue and Market Share Analysis of Marinus Pharmaceuticals, Inc.

    • Table Product and Service Introduction of Marinus Pharmaceuticals, Inc.

    • Table Company Profile and Development Status of AbbVie Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie Inc.

    • Figure Sales and Growth Rate Analysis of AbbVie Inc.

    • Figure Revenue and Market Share Analysis of AbbVie Inc.

    • Table Product and Service Introduction of AbbVie Inc.

    • Table Company Profile and Development Status of IntelGenx Corp

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of IntelGenx Corp

    • Figure Sales and Growth Rate Analysis of IntelGenx Corp

    • Figure Revenue and Market Share Analysis of IntelGenx Corp

    • Table Product and Service Introduction of IntelGenx Corp

    • Table Company Profile and Development Status of INVENT Pharmaceuticals, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of INVENT Pharmaceuticals, Inc

    • Figure Sales and Growth Rate Analysis of INVENT Pharmaceuticals, Inc

    • Figure Revenue and Market Share Analysis of INVENT Pharmaceuticals, Inc

    • Table Product and Service Introduction of INVENT Pharmaceuticals, Inc

    • Table Company Profile and Development Status of Amorsa Therapeutics Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amorsa Therapeutics Inc.

    • Figure Sales and Growth Rate Analysis of Amorsa Therapeutics Inc.

    • Figure Revenue and Market Share Analysis of Amorsa Therapeutics Inc.

    • Table Product and Service Introduction of Amorsa Therapeutics Inc.

    • Table Company Profile and Development Status of F. Hoffmann-La Roche Ltd.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of F. Hoffmann-La Roche Ltd.

    • Figure Sales and Growth Rate Analysis of F. Hoffmann-La Roche Ltd.

    • Figure Revenue and Market Share Analysis of F. Hoffmann-La Roche Ltd.

    • Table Product and Service Introduction of F. Hoffmann-La Roche Ltd.

    • Table Company Profile and Development Status of F Hoffmann-La Roche Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann-La Roche Ltd

    • Figure Sales and Growth Rate Analysis of F Hoffmann-La Roche Ltd

    • Figure Revenue and Market Share Analysis of F Hoffmann-La Roche Ltd

    • Table Product and Service Introduction of F Hoffmann-La Roche Ltd

    • Table Company Profile and Development Status of Avineuro Pharmaceuticals, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Avineuro Pharmaceuticals, Inc

    • Figure Sales and Growth Rate Analysis of Avineuro Pharmaceuticals, Inc

    • Figure Revenue and Market Share Analysis of Avineuro Pharmaceuticals, Inc

    • Table Product and Service Introduction of Avineuro Pharmaceuticals, Inc

    • Table Company Profile and Development Status of Addex Therapeutics Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Addex Therapeutics Ltd

    • Figure Sales and Growth Rate Analysis of Addex Therapeutics Ltd

    • Figure Revenue and Market Share Analysis of Addex Therapeutics Ltd

    • Table Product and Service Introduction of Addex Therapeutics Ltd

    • Table Company Profile and Development Status of GW Pharmaceuticals Plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GW Pharmaceuticals Plc

    • Figure Sales and Growth Rate Analysis of GW Pharmaceuticals Plc

    • Figure Revenue and Market Share Analysis of GW Pharmaceuticals Plc

    • Table Product and Service Introduction of GW Pharmaceuticals Plc

    • Table Company Profile and Development Status of Boehringer Ingelheim GmbH.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim GmbH.

    • Figure Sales and Growth Rate Analysis of Boehringer Ingelheim GmbH.

    • Figure Revenue and Market Share Analysis of Boehringer Ingelheim GmbH.

    • Table Product and Service Introduction of Boehringer Ingelheim GmbH.

    • Table Company Profile and Development Status of Adamed Sp. z o.o.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Adamed Sp. z o.o.

    • Figure Sales and Growth Rate Analysis of Adamed Sp. z o.o.

    • Figure Revenue and Market Share Analysis of Adamed Sp. z o.o.

    • Table Product and Service Introduction of Adamed Sp. z o.o.

    • Table Company Profile and Development Status of Eisai Co., Ltd.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eisai Co., Ltd.

    • Figure Sales and Growth Rate Analysis of Eisai Co., Ltd.

    • Figure Revenue and Market Share Analysis of Eisai Co., Ltd.

    • Table Product and Service Introduction of Eisai Co., Ltd.

    • Table Company Profile and Development Status of Edgemont Pharmaceuticals, LLC

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Edgemont Pharmaceuticals, LLC

    • Figure Sales and Growth Rate Analysis of Edgemont Pharmaceuticals, LLC

    • Figure Revenue and Market Share Analysis of Edgemont Pharmaceuticals, LLC

    • Table Product and Service Introduction of Edgemont Pharmaceuticals, LLC

    • Table Company Profile and Development Status of Eli Lilly and Company

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly and Company

    • Figure Sales and Growth Rate Analysis of Eli Lilly and Company

    • Figure Revenue and Market Share Analysis of Eli Lilly and Company

    • Table Product and Service Introduction of Eli Lilly and Company

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US